Price movement over the last 24 hours
ARK Genomic Revolution ETF vs Global X Robo Global Robotics & Automation ETF — how do they compare? ARK Genomic Revolution ETF trades at $40.83, while Global X Robo Global Robotics & Automation ETF trades at $81.56. The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Global X Robo Global Robotics & Automation ETF nearer its low. Which is the better fit depends on your goals.
| ARKG | ROBO | |
|---|---|---|
Sector | Sector/Thematic | Sector/Thematic |
52-Week High | $43.57 | $90.34 |
52-Week Low | $23.09 | $60.15 |
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
ROBO trades at $82.96, up 0.45% today, but technical indicators signal a bearish trend with selling pressure outweighing buying signals. The stock faces resistance near $83 with support at $79. Recent news highlights the ETF's rebalancing toward AI infrastructure and physical automation, positioning it for the expanding robotics market. Financial ratios remain undisclosed, requiring deeper fundamental review.
Outlook is cautious due to bearish technicals and cyclical exposure, but long-term potential exists in AI-driven automation. Risks include market volatility and competition, while institutional interest in thematic ETFs may provide support. Investors should weigh near-term headwinds against secular growth in robotics.
Trailing returns across standard periods
Latest headlines on both assets
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →ROBO is a thematic ETF that tracks the global robotics and automation industry. It provides diversified exposure to companies leading in industrial robotics, 3D printing, and surgical systems, with holdings like Intuitive Surgical and Zebra Technologies.
Read more on ROBO →